Advertisement

Neurocritical Care

, Volume 7, Issue 2, pp 175–184 | Cite as

Use of Prophylactic Anticonvulsants in Neurologic Critical Care: A Critical Appraisal

  • Kenneth C. Liu
  • Anish BhardwajEmail author
Review

Abstract

Seizures are commonly encountered in the setting of brain injury in neurologic critical care. Though seizure prophylaxis with the use of antiepileptic drugs is frequently utilized in variety of brain injury paradigms, it is often not based on evidence and is controversial. Significant difficulties arise from interpretation of supporting literature due to lack of definitions for early-vs.-late-seizures, variable end points with seizure prophylaxis, as well as methodologic inconsistencies for seizure detection. This descriptive review summarizes the existing literature on the use of prophylactic anticonvulsants in clinical paradigms commonly encountered in neurologic critical care and highlights the important controversies concerning their use.

Keywords

Seizures Neurologic critical care Anticonvulsants Epilepsy 

Notes

Acknowledgments

Source of Support: This work was supported by Public Health Service NIH grant NS046379. The authors thank Tzipora Sofare, MA, for her editorial assistance in preparing this manuscript.

References

  1. 1.
    Kalsbeek WD, McLaurin RL, Harris BS 3rd, Miller JD. The National Head and Spinal Cord Injury Survey: major findings. J Neurosurg 1980;Suppl:S19–31.PubMedGoogle Scholar
  2. 2.
    Jennett B. Epilepsy after non-missile head injuries. Scott Med J 1973;18:8–13.PubMedGoogle Scholar
  3. 3.
    Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998;338:20–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Weiss GH, Salazar AM, Vance SC, et al. Predicting posttraumatic epilepsy in penetrating head injury. Arch Neurol 1986;43:771–3.PubMedGoogle Scholar
  5. 5.
    Rapport RL 2nd, Penry JK. A survey of attitudes toward the pharmacological prophylaxis of posttraumatic epilepsy. J Neurosurg 1973;38:159–66.PubMedGoogle Scholar
  6. 6.
    Servit Z, Musil F. Prophylactic treatment of posttraumatic epilepsy: results of a long-term follow-up in Czechoslovakia. Epilepsia 1981;22:315–20.PubMedGoogle Scholar
  7. 7.
    Wohns RN, Wyler AR. Prophylactic phenytoin in severe head injuries. J Neurosurg 1979;51:507–9.PubMedGoogle Scholar
  8. 8.
    Young B, Rapp RP, Norton JA, et al. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg 1983;58:231–5.PubMedGoogle Scholar
  9. 9.
    Glotzner FL, Haubitz I, Miltner F, et al. Seizure prevention using carbamazepine following severe brain injuries. Neurochirurgia (Stuttg) 1983;26:66–79.Google Scholar
  10. 10.
    McQueen JK, Blackwood DH, Harris P, et al. Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis. J Neurol Neurosurg Psychiatry 1983;46:899–904.PubMedGoogle Scholar
  11. 11.
    Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497–502.PubMedCrossRefGoogle Scholar
  12. 12.
    Dikmen SS, Temkin NR, Miller B, et al. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991;265:1271–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593–600.PubMedGoogle Scholar
  14. 14.
    Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev 2001;(4):CD000173.Google Scholar
  15. 15.
    Chadwick D. Seizures and epilepsy after traumatic brain injury. Lancet 2000;355:334–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Haltiner AM, Newell DW, Temkin NR, et al. Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. J Neurosurg 1999;91:588–92.PubMedGoogle Scholar
  17. 17.
    Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology 1980;30:683–9.PubMedGoogle Scholar
  18. 18.
    Jennett B. Epilepsy and acute traumatic intracranial haematoma. Neurol Neurosurg Psychiatry 1975;38:378–81.Google Scholar
  19. 19.
    Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003;60:208–14.PubMedCrossRefGoogle Scholar
  20. 20.
    Rhoney DH, Tipps LB, Murry KR, et al. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology 2000;55:258–65.PubMedGoogle Scholar
  21. 21.
    Butzkueven H, Evans AH, Pitman A, et al. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000;55:1315–20.PubMedGoogle Scholar
  22. 22.
    Ohman J. Hypertension as a risk factor for epilepsy after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 1990;27:578–81.PubMedCrossRefGoogle Scholar
  23. 23.
    Keranen T, Tapaninaho A, Hernesniemi J, et al. Late epilepsy after aneurysm operations. Neurosurgery 1985;17:897–900.PubMedCrossRefGoogle Scholar
  24. 24.
    Baker CJ, Prestigiacomo CJ, Solomon RA Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery 1995;37:863–70.PubMedCrossRefGoogle Scholar
  25. 25.
    Lin CL, Dumont AS, Lieu AS, et al. Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:978–85.PubMedGoogle Scholar
  26. 26.
    Sbeih I, Tamas LB, O’Laoire SA Epilepsy after operation for aneurysms. Neurosurgery 1986;19:784–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Bidzinski J, Marchel A, Sherif A Risk of epilepsy after aneurysm operations. Acta Neurochir (Wien) 1992;119:49–52.CrossRefGoogle Scholar
  28. 28.
    Ogden JA, Utley T, Mee EW Neurological and psychosocial outcome 4 to 7 years after subarachnoid hemorrhage. Neurosurgery 1997;41:25–34.PubMedCrossRefGoogle Scholar
  29. 29.
    Pinto AN, Canhao P, Ferro JM Seizures at the onset of subarachnoid haemorrhage. J Neurol 1996;243:161–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Sundaram MB, Chow F Seizures associated with spontaneous subarachnoid hemorrhage. Can J Neurol Sci 1986;13:229–31.PubMedGoogle Scholar
  31. 31.
    Dennis LJ, Claassen J, Hirsch LJ, et al. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery 2002;51:1136–43.PubMedCrossRefGoogle Scholar
  32. 32.
    Byrne JV, Boardman P, Ioannidis I, et al. Seizures after aneurysmal subarachnoid hemorrhage treated with coil embolization. Neurosurgery 2003;52:545–52; discussion 550–2.Google Scholar
  33. 33.
    Molyneux AJ, Kerr RS, Yu LM, et al. International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809–17.PubMedCrossRefGoogle Scholar
  34. 34.
    Rosengart AJ, Novakovic R, Dezheng H, et al. Impact of prophylactic anticonvulsive use on outcome in subarachnoid hemorrhage. Stroke 2004;35:250.Google Scholar
  35. 35.
    Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Chumnanvej S, Dunn IF, Kim DH, et al. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery 2007;60:99–102.PubMedCrossRefGoogle Scholar
  37. 37.
    Tartara A, Galimberti CA, Manni R, et al. Differentail effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharamcokinetics in epileptic patients. Br J Clin Pharmacol 1991;32:335–40.PubMedGoogle Scholar
  38. 38.
    Koch S, Gidal BE Phenytoin and cognitive decline. Stroke 2005;36(10):2070–1.PubMedGoogle Scholar
  39. 39.
    Naval NS, Stevens RD, Mirski MA, Bhardwaj A Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med 2006;34:511–24.PubMedCrossRefGoogle Scholar
  40. 40.
    Sirven JI, Wingerchuk DM, Drazkowski JF, et al. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 2004;79:1489–94.PubMedCrossRefGoogle Scholar
  41. 41.
    Lund M Epilepsy in association with intracranial tumour. Acta Psychiatr Neurol Scand Suppl 1952;81:1–149.PubMedGoogle Scholar
  42. 42.
    Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886–93.PubMedGoogle Scholar
  43. 43.
    Wassenaar T, Feldstein D Do prophylactic anticonvulsants in patients with brain tumors decrease the incidence of seizures? WMJ 2005;104:9–10.PubMedGoogle Scholar
  44. 44.
    Cockey GH, Amann ST, Reents SB, Lynch JW Jr Stevens–Johnson syndrome resulting from whole-brain radiation and phenytoin. Am J Clin Oncol 1996;19:32–4.PubMedCrossRefGoogle Scholar
  45. 45.
    Delattre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988;38:194–8.PubMedGoogle Scholar
  46. 46.
    Mamon HJ, Wen PY, Burns AC, Loeffler JS Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia 1999;40:341–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Mattson RH, Cramer JA, Collins JF A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992;327:765–71.PubMedCrossRefGoogle Scholar
  48. 48.
    Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145–51.PubMedCrossRefGoogle Scholar
  49. 49.
    Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2003;2:404–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Berger AR, Lipton RB, Lesser ML, et al. Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 1988;38:1363–5.PubMedGoogle Scholar
  51. 51.
    Vespa PM, O’Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003;60:1441–6.PubMedGoogle Scholar
  52. 52.
    Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. A statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1999;30:905–15.PubMedGoogle Scholar
  53. 53.
    Cervoni L, Artico M, Salvati M, et al. Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev 1994;17:185–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Forsgren L, Bucht G, Eriksson S, Bergmark L Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996; 37:224–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Meyer JS, Charney JZ, Rivera VM, Mathew NT Cerebral embolization: prospective clinical analysis of 42 cases. Stroke 1971;2:541–54.PubMedGoogle Scholar
  56. 56.
    Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754–62.PubMedGoogle Scholar
  57. 57.
    Arboix A, Garcia-Eroles L, Massons JB, et al. Predictive factors of early seizures after acute cerebrovascular disease. Stroke 1997;28:1590–4.PubMedGoogle Scholar
  58. 58.
    Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000;57:1617–22.PubMedCrossRefGoogle Scholar
  59. 59.
    Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997;315:1582–7.PubMedGoogle Scholar
  60. 60.
    Giroud M, Gras P, Fayolle H, et al. Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 1994; 35:959–64.PubMedCrossRefGoogle Scholar
  61. 61.
    Lancman ME, Golimstok A, Norscini J, Granillo R Risk factors for developing seizures after a stroke. Epilepsia 1993;34:141–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Reith J, Jorgensen HS, Nakayama H, et al. Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997;28:1585–9.PubMedGoogle Scholar
  63. 63.
    So EL, Annegers JF, Hauser WA, et al. Population-based study of seizure disorders after cerebral infarction. Neurology 1996;46:350–5.PubMedGoogle Scholar
  64. 64.
    De Carolis P, D’Alessandro R, Ferrara R, et al. Late seizures in patients with internal carotid and middle cerebral artery occlusive disease following ischaemic events. Neurol Neurosurg Psychiatry 1984;47:1345–7.Google Scholar
  65. 65.
    Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke Arch Neurol 1990;47:157–60.PubMedGoogle Scholar
  66. 66.
    Shinton RA, Gill JS, Melnick SC, et al. The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. Neurol Neurosurg Psychiatry 1988;51:273–6.Google Scholar
  67. 67.
    Alvarez-Sabin J, Montaner J, Padro L, et al. Gabapentin in late-onset poststroke seizures. Neurology 2002;59:1991–3.PubMedGoogle Scholar
  68. 68.
    Leker RR, Neufeld MY Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Res 2003;42:187–203.CrossRefGoogle Scholar
  69. 69.
    Goldstein LB Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. Neurology 1995;45:865–71.PubMedGoogle Scholar
  70. 70.
    Goldstein LB Influence of common drugs and related factors on stroke outcome. Curr Opin Neurol 1997;10:52–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664–70.PubMedCrossRefGoogle Scholar
  72. 72.
    Masuhr F, Busch M, Amberger N, et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 2006;13:852–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Ferro JM, Correia M, Rosas MJ, et al. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2003;15:78–83.PubMedCrossRefGoogle Scholar
  74. 74.
    Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007;119(2):e399–407.Google Scholar
  75. 75.
    Gunduz A, Beskardes AF, Kutlu A, et al. Herpes encephalitis as a cause of nonconvulsive status epilepticus. Pediatrics 2007;119:e399–407.CrossRefGoogle Scholar
  76. 76.
    Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593–600.PubMedCrossRefGoogle Scholar
  77. 77.
    Calabresi P, Cupini LM, Centonze D, et al. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 2003;53:693–702.PubMedCrossRefGoogle Scholar
  78. 78.
    Ramael S, Daoust A, Otoul C, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006;47:1128–35.PubMedCrossRefGoogle Scholar
  79. 79.
    Falip M, Carreno M, Amaro S, et al. Use of levetiracetam in hospitalized patients. Epilepsia 2006;47:2186–8.PubMedCrossRefGoogle Scholar
  80. 80.
    Wheless JW, Vazquez BR, Kanner AM, et al. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004;63:1507–8.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  1. 1.Department of Neurological SurgeryOregon Health and Science UniversityPortlandUSA
  2. 2.Department of NeurologyOregon Health and Science UniversityPortlandUSA
  3. 3.Department of Anesthesiology and Peri-Operative MedicineOregon Health and Science UniversityPortlandUSA

Personalised recommendations